does glp 1 help with autoimmune GLP-1 Agonists in Disease Using GLP-1 Agonists with Biologics

The endocannabinoid system is known to be involved in various digestive disorders, such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD)

Most are administered via subcutaneous injection, with dosing frequencies ranging from once daily to once weekly, depending on the specific formulation

Practical decision framing in the research-use community: if the research interest is structural repair, soft-tissue work, or skin remodeling alone, GLOW covers those bases

Andrew Huberman mentioned using the peptide for L5 vertebral compression pain, reporting pain elimination after just 2 injections